169 related articles for article (PubMed ID: 1317982)
1. Comparative efficacy of three doses of the genetically engineered Aujeszky's disease virus vaccine strain 783 in pigs with maternal antibodies.
Kimman TG
Vaccine; 1992; 10(6):363-5. PubMed ID: 1317982
[TBL] [Abstract][Full Text] [Related]
2. Intranasal vaccination of pigs against Aujeszky's disease: comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titres.
Van Oirschot JT
Res Vet Sci; 1987 Jan; 42(1):12-6. PubMed ID: 3029845
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of an intranasal immunization with gEgC and gEgI double-deletion mutants of Aujeszky's disease virus in maternally immune pigs and the effects of a successive intramuscular booster with commercial vaccines.
Nauwynck HJ; Labarque GG; Pensaert MB
Zentralbl Veterinarmed B; 1999 Dec; 46(10):713-22. PubMed ID: 10676150
[TBL] [Abstract][Full Text] [Related]
4. Intranasal vaccination of pigs against Aujeszky's disease: protective immunity at 2 weeks, 2 months and 4 months after vaccination in pigs with maternal antibodies.
van Oirschot JT
Vet Microbiol; 1991 Apr; 27(2):103-13. PubMed ID: 1648282
[TBL] [Abstract][Full Text] [Related]
5. Intranasal vaccination of pigs against Aujeszky's disease. 4. Comparison with one or two doses of an inactivated vaccine in pigs with moderate maternal antibody titres.
Van Oirschot JT; De Leeuw PW
Vet Microbiol; 1985 Aug; 10(5):401-8. PubMed ID: 2996212
[TBL] [Abstract][Full Text] [Related]
6. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I.
van Oirschot JT; Terpstra C; Moormann RJ; Berns AJ; Gielkens AL
Vet Rec; 1990 Nov; 127(18):443-6. PubMed ID: 2177288
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma secretion and proliferative responses of peripheral blood mononuclear cells after vaccination of pigs against Aujeszky's disease in the presence of maternal immunity.
Pomorska-Mól M; Markowska-Daniel I
FEMS Immunol Med Microbiol; 2010 Apr; 58(3):405-11. PubMed ID: 20180849
[TBL] [Abstract][Full Text] [Related]
8. Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines.
Vannier P; Hutet E; Bourgueil E; Cariolet R
Vet Microbiol; 1991 Nov; 29(3-4):213-23. PubMed ID: 1663287
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity in Aujeszky's disease virus structural glycoprotein gVI (gp50) in swine.
Mukamoto M; Watanabe I; Kobayashi Y; Icatlo FC; Ishii H; Kodama Y
Vet Microbiol; 1991 Oct; 29(2):109-21. PubMed ID: 1660638
[TBL] [Abstract][Full Text] [Related]
10. Effect of experimental infection with pseudorabies (Aujeszky's disease) virus on pigs with maternal immunity from vaccinated sows.
Andries K; Pensaert MB; Vandeputte J
Am J Vet Res; 1978 Aug; 39(8):1282-5. PubMed ID: 211882
[TBL] [Abstract][Full Text] [Related]
11. Influence of vaccine medium and vaccination schedules on the induction of active immunity against Aujeszky's disease in maternally immune pigs.
De Smet K; De Waele K; Pensaert M
Res Vet Sci; 1994 Jan; 56(1):89-94. PubMed ID: 8146460
[TBL] [Abstract][Full Text] [Related]
12. Extent and duration of virulent virus excretion upon challenge of pigs vaccinated with different glycoprotein-deleted Aujeszky's disease vaccines.
Pensaert MB; De Smet K; De Waele K
Vet Microbiol; 1990 Apr; 22(2-3):107-17. PubMed ID: 2162094
[TBL] [Abstract][Full Text] [Related]
13. Intranasal vaccination of pigs against Aujeszky's disease: comparison with inactivated vaccines in pigs with low maternal antibody titres.
De Leeuw PW; Van Oirschot JT
Res Vet Sci; 1985 Jul; 39(1):34-8. PubMed ID: 2994188
[TBL] [Abstract][Full Text] [Related]
14. Aujeszky's disease vaccination and infection of pigs with maternal immunity: effects on cell- and antibody-mediated immunity.
Wittmann G; Ohlinger V
Arch Virol; 1987; 92(1-2):87-101. PubMed ID: 3026291
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of swinepox virus as a vaccine vector in pigs using an Aujeszky's disease (pseudorabies) virus gene insert coding for glycoproteins gp50 and gp63.
van der Leek ML; Feller JA; Sorensen G; Isaacson W; Adams CL; Borde DJ; Pfeiffer N; Tran T; Moyer RW; Gibbs EP
Vet Rec; 1994 Jan; 134(1):13-8. PubMed ID: 8128561
[TBL] [Abstract][Full Text] [Related]
16. [Trial of vaccination against Aujeszky's disease].
Motovski A; Veselinova A; Dobrev V
Vet Med Nauki; 1980; 17(5):32-7. PubMed ID: 6262995
[TBL] [Abstract][Full Text] [Related]
17. Influence of vaccination route on the efficacy of Aujeszky's disease deletion-mutant vaccine.
Hasebe H; Osorio FA; Hogg A; Liauw H; Bartkoski MJ; Sugiyama M
J Vet Med Sci; 1992 Aug; 54(4):693-8. PubMed ID: 1327180
[TBL] [Abstract][Full Text] [Related]
18. Influence of passive immunity on pig immunization with deleted Aujeszky's disease vaccines measured by the amount of wild virus excretion after challenge.
Vannier P; Hutet E; Cariolet R
Vet Microbiol; 1995 Jan; 43(1):53-63. PubMed ID: 7716884
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of maternally immune pigs with a live Aujeszky's disease vaccine by coarse spray and other routes.
Chong YC; Ng FK
Vet Microbiol; 1994 Mar; 39(1-2):117-24. PubMed ID: 8203117
[TBL] [Abstract][Full Text] [Related]
20. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV.
Kit S; Kit M; McConnell S; Lawhorn B
Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
